Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV

Heena Brahmbhatt, Michael Boivin, Victor Ssempijja, Godfrey Kigozi, Joseph Kagaayi, David Serwadda, Ronald H Gray

Research output: Contribution to journalArticle

Abstract

Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children. Methods: Prospective study of 329 mothers and children aged 0-6 years to assess neurodevelopment. Results stratified by the maternal (M) and child (C) HIV status (MHIV-/CHIV-, MHIV+/CHIV-, and MHIV+/CHIV+). Gross Motor, Visual Reception, Fine Motor, Receptive, and Expressive Language scores were assessed by Mullen Scales of Early Learning. Global cognitive function was derived from an Early Learning Composite (ELC) score. Standardized weight and height for age z scores were constructed, and the lowest 15% cutoff defined disability. Generalized linear models were used to estimate prevalence rate ratios (PRR) adjusted for the child's age, weight, and height. In HIV-positive children, generalized linear models assessed the impact of ART initiation and duration on neurodevelopment. Results: Compared with MHIV-/CHIV- children, HIV-positive children were more likely to have global deficits in all measures of neurodevelopment except gross motor skills, whereas in MHIV+/CHIV- children, there was impairment in receptive language [adjusted PRR = 2.67; confidence interval (CI): 1.08 to 6.60] and the ELC (adjusted PRR = 2.94; CI: 1.11 to 7.82). Of the children born to HIV-positive mothers, HIV-positive children did worse than MHIV+/CHIV- only in visual reception skills (adjusted PRR = 2.86; CI: 1.23 to 6.65). Of the 116 HIV-positive children, 44% had initiated ART. Compared with ART duration of

Original languageEnglish (US)
Pages (from-to)316-322
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume67
Issue number3
StatePublished - 2014

Fingerprint

HIV
Therapeutics
Mothers
Learning
Confidence Intervals
Linear Models
Language
Weights and Measures
Motor Skills
Cognition
Prospective Studies

Keywords

  • ARTs
  • HIV
  • HIV-affected children
  • HIV-infected children
  • Neurodevelopment

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Brahmbhatt, H., Boivin, M., Ssempijja, V., Kigozi, G., Kagaayi, J., Serwadda, D., & Gray, R. H. (2014). Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV. Journal of Acquired Immune Deficiency Syndromes, 67(3), 316-322.

Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV. / Brahmbhatt, Heena; Boivin, Michael; Ssempijja, Victor; Kigozi, Godfrey; Kagaayi, Joseph; Serwadda, David; Gray, Ronald H.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 67, No. 3, 2014, p. 316-322.

Research output: Contribution to journalArticle

Brahmbhatt, H, Boivin, M, Ssempijja, V, Kigozi, G, Kagaayi, J, Serwadda, D & Gray, RH 2014, 'Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV', Journal of Acquired Immune Deficiency Syndromes, vol. 67, no. 3, pp. 316-322.
Brahmbhatt H, Boivin M, Ssempijja V, Kigozi G, Kagaayi J, Serwadda D et al. Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV. Journal of Acquired Immune Deficiency Syndromes. 2014;67(3):316-322.
Brahmbhatt, Heena ; Boivin, Michael ; Ssempijja, Victor ; Kigozi, Godfrey ; Kagaayi, Joseph ; Serwadda, David ; Gray, Ronald H. / Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV. In: Journal of Acquired Immune Deficiency Syndromes. 2014 ; Vol. 67, No. 3. pp. 316-322.
@article{2e95cc845523421b8542a835f81576f8,
title = "Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV",
abstract = "Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children. Methods: Prospective study of 329 mothers and children aged 0-6 years to assess neurodevelopment. Results stratified by the maternal (M) and child (C) HIV status (MHIV-/CHIV-, MHIV+/CHIV-, and MHIV+/CHIV+). Gross Motor, Visual Reception, Fine Motor, Receptive, and Expressive Language scores were assessed by Mullen Scales of Early Learning. Global cognitive function was derived from an Early Learning Composite (ELC) score. Standardized weight and height for age z scores were constructed, and the lowest 15{\%} cutoff defined disability. Generalized linear models were used to estimate prevalence rate ratios (PRR) adjusted for the child's age, weight, and height. In HIV-positive children, generalized linear models assessed the impact of ART initiation and duration on neurodevelopment. Results: Compared with MHIV-/CHIV- children, HIV-positive children were more likely to have global deficits in all measures of neurodevelopment except gross motor skills, whereas in MHIV+/CHIV- children, there was impairment in receptive language [adjusted PRR = 2.67; confidence interval (CI): 1.08 to 6.60] and the ELC (adjusted PRR = 2.94; CI: 1.11 to 7.82). Of the children born to HIV-positive mothers, HIV-positive children did worse than MHIV+/CHIV- only in visual reception skills (adjusted PRR = 2.86; CI: 1.23 to 6.65). Of the 116 HIV-positive children, 44{\%} had initiated ART. Compared with ART duration of",
keywords = "ARTs, HIV, HIV-affected children, HIV-infected children, Neurodevelopment",
author = "Heena Brahmbhatt and Michael Boivin and Victor Ssempijja and Godfrey Kigozi and Joseph Kagaayi and David Serwadda and Gray, {Ronald H}",
year = "2014",
language = "English (US)",
volume = "67",
pages = "316--322",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Neurodevelopmental benefits of antiretroviral therapy in ugandan children aged 0-6 years with HIV

AU - Brahmbhatt, Heena

AU - Boivin, Michael

AU - Ssempijja, Victor

AU - Kigozi, Godfrey

AU - Kagaayi, Joseph

AU - Serwadda, David

AU - Gray, Ronald H

PY - 2014

Y1 - 2014

N2 - Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children. Methods: Prospective study of 329 mothers and children aged 0-6 years to assess neurodevelopment. Results stratified by the maternal (M) and child (C) HIV status (MHIV-/CHIV-, MHIV+/CHIV-, and MHIV+/CHIV+). Gross Motor, Visual Reception, Fine Motor, Receptive, and Expressive Language scores were assessed by Mullen Scales of Early Learning. Global cognitive function was derived from an Early Learning Composite (ELC) score. Standardized weight and height for age z scores were constructed, and the lowest 15% cutoff defined disability. Generalized linear models were used to estimate prevalence rate ratios (PRR) adjusted for the child's age, weight, and height. In HIV-positive children, generalized linear models assessed the impact of ART initiation and duration on neurodevelopment. Results: Compared with MHIV-/CHIV- children, HIV-positive children were more likely to have global deficits in all measures of neurodevelopment except gross motor skills, whereas in MHIV+/CHIV- children, there was impairment in receptive language [adjusted PRR = 2.67; confidence interval (CI): 1.08 to 6.60] and the ELC (adjusted PRR = 2.94; CI: 1.11 to 7.82). Of the children born to HIV-positive mothers, HIV-positive children did worse than MHIV+/CHIV- only in visual reception skills (adjusted PRR = 2.86; CI: 1.23 to 6.65). Of the 116 HIV-positive children, 44% had initiated ART. Compared with ART duration of

AB - Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children. Methods: Prospective study of 329 mothers and children aged 0-6 years to assess neurodevelopment. Results stratified by the maternal (M) and child (C) HIV status (MHIV-/CHIV-, MHIV+/CHIV-, and MHIV+/CHIV+). Gross Motor, Visual Reception, Fine Motor, Receptive, and Expressive Language scores were assessed by Mullen Scales of Early Learning. Global cognitive function was derived from an Early Learning Composite (ELC) score. Standardized weight and height for age z scores were constructed, and the lowest 15% cutoff defined disability. Generalized linear models were used to estimate prevalence rate ratios (PRR) adjusted for the child's age, weight, and height. In HIV-positive children, generalized linear models assessed the impact of ART initiation and duration on neurodevelopment. Results: Compared with MHIV-/CHIV- children, HIV-positive children were more likely to have global deficits in all measures of neurodevelopment except gross motor skills, whereas in MHIV+/CHIV- children, there was impairment in receptive language [adjusted PRR = 2.67; confidence interval (CI): 1.08 to 6.60] and the ELC (adjusted PRR = 2.94; CI: 1.11 to 7.82). Of the children born to HIV-positive mothers, HIV-positive children did worse than MHIV+/CHIV- only in visual reception skills (adjusted PRR = 2.86; CI: 1.23 to 6.65). Of the 116 HIV-positive children, 44% had initiated ART. Compared with ART duration of

KW - ARTs

KW - HIV

KW - HIV-affected children

KW - HIV-infected children

KW - Neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=84922016370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922016370&partnerID=8YFLogxK

M3 - Article

C2 - 25314252

AN - SCOPUS:84922016370

VL - 67

SP - 316

EP - 322

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -